TruBridge, Inc.
TruBridge, Inc. (TBRG) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · TBRG · as of Jun 8, 2026
Activity summary
Buy transactions
15
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
TruBridge, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
TBRG insider buying and selling by quarter
TBRG insider selling · TBRG insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · TBRG ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
TBRG executive sell shares · TBRG board member insider trading · TBRG insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 8, 2026 | Fowler Christopher L President and CEO · Director | Award | 19,683 | — | Form 4 |
| Apr 8, 2026 | Bassi Vinay CFO | Award | 12,698 | — | Form 4 |
| Apr 8, 2026 | Daughton Michael Chief Business Officer | Award | 10,572 | — | Form 4 |
| Apr 8, 2026 | Plessner Kevin General Counsel | Award | 2,598 | — | Form 4 |
| Apr 8, 2026 | Harse David General Manager Patient Care | Award | 5,079 | — | Form 4 |
| Apr 8, 2026 | Wilson Merideth Financial Health GM | Award | 5,206 | — | Form 4 |
| Apr 8, 2026 | MacIntyre Vita Controller | Award | 909 | — | Form 4 |
| Mar 27, 2026 | MacIntyre Vita Controller | Other | 187 | $3K | Form 4 |
| Mar 13, 2026 | Wilson Merideth Financial Health GM | Other | 604 | $10K | Form 4 |
| Mar 13, 2026 | Plessner Kevin General Counsel | Other | 340 | $6K | Form 4 |
| Mar 16, 2026 | Plessner Kevin General Counsel | Other | 825 | $15K | Form 4 |
| Mar 13, 2026 | MacIntyre Vita Controller | Other | 125 | $2K | Form 4 |
| Mar 13, 2026 | Harse David General Manager Patient Care | Other | 571 | $10K | Form 4 |
| Mar 16, 2026 | Harse David General Manager Patient Care | Other | 1,098 | $19K | Form 4 |
| Mar 13, 2026 | Fowler Christopher L President and CEO · Director | Other | 2,213 | $38K | Form 4 |
| Mar 16, 2026 | Fowler Christopher L President and CEO · Director | Other | 5,909 | $104K | Form 4 |
| Mar 13, 2026 | DYE DAVID A Director | Other | 1,285 | $22K | Form 4 |
| Mar 16, 2026 | DYE DAVID A Director | Other | 2,793 | $49K | Form 4 |
| Mar 13, 2026 | Bassi Vinay CFO | Other | 1,758 | $30K | Form 4 |
| Mar 16, 2026 | Bassi Vinay CFO | Other | 3,965 | $70K | Form 4 |
| Mar 9, 2026 | Harse David General Manager Patient Care | Other | 377 | $7K | Form 4 |
| Mar 9, 2026 | Fowler Christopher L President and CEO · Director | Other | 2,093 | $39K | Form 4 |
| Dec 31, 2024 | DYE DAVID A Director | Other | 9,516 | — | Form 4 |
| Mar 9, 2026 | DYE DAVID A Director | Other | 1,416 | $26K | Form 4 |
| Mar 9, 2026 | Plessner Kevin General Counsel | Other | 280 | $5K | Form 4 |
Fowler Christopher L
President and CEO · Director
Date
Apr 8
Shares
19,683
Price
—
Value
—
Wilson Merideth
Financial Health GM
Date
Mar 13
Shares
604
Price
$17.31
Value
$10K
Harse David
General Manager Patient Care
Date
Mar 13
Shares
571
Price
$17.31
Value
$10K
Harse David
General Manager Patient Care
Date
Mar 16
Shares
1,098
Price
$17.59
Value
$19K
Fowler Christopher L
President and CEO · Director
Date
Mar 13
Shares
2,213
Price
$17.31
Value
$38K
Fowler Christopher L
President and CEO · Director
Date
Mar 16
Shares
5,909
Price
$17.59
Value
$104K
Harse David
General Manager Patient Care
Date
Mar 9
Shares
377
Price
$18.47
Value
$7K
Fowler Christopher L
President and CEO · Director
Date
Mar 9
Shares
2,093
Price
$18.47
Value
$39K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About TBRG insider trading
TBRG insider trades
TruBridge, Inc. (TBRG) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Daughton Michael (Chief Business Officer), Fowler Christopher L (President and CEO · Director), Plessner Kevin (General Counsel). Over the past 12 months, 5 insiders have filed transactions with the SEC. TBRG insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For TruBridge, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
TBRG insider trading · 5 questionsThe insiders of TruBridge, Inc. (TBRG) include executives and directors such as Daughton Michael (Chief Business Officer), Fowler Christopher L (President and CEO · Director), Plessner Kevin (General Counsel), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026